R&D |

Research & Development Pipeline

Area Asset/ Partner Indication Development Pre-clinical Clinical Regulatory Submission

Oncology

Angrelide

NSCLC

Central Nervous System

ZolpiMist™

Insomnia

Sumatriptan

Migraine

Medical Grade Cannabis

Zelira Therapeutics

Not disclosed

Cann Pharma

Drug resistant epilepsy, melonoma, motion sickness

Development Partnership

Ordesa

Not disclosed

Sanofi

Not disclosed